Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Update includes a new operating status notice and version bump to v3.2.0; removal of the previous v3.1.0 note indicates version update.
    Difference
    1%
    Check dated 2025-10-07T23:22:53.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated page version from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.0%
    Check dated 2025-09-30T02:46:36.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Core content on drug safety and related topics has been removed, reducing important information about drug safety, counterfeit drugs, pharmaceutical preparations, and substandard drugs.
    Difference
    0.1%
    Check dated 2025-09-22T23:38:11.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Updated to revision v3.0.2, replacing v3.0.1; the Back to Top link was removed. No substantive changes to core content like pricing or availability are indicated.
    Difference
    0.1%
    Check dated 2025-09-15T19:22:04.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.1%
    Check dated 2025-09-08T15:01:20.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of detailed drug information for Remdesivir and the inclusion of various locations and names associated with COVID-19 treatment. Notably, the facility names and specific locations have been revised to reflect current data.
    Difference
    8%
    Check dated 2025-09-01T09:26:23.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.